Mercer Global Advisors Inc. ADV Buys 294 Shares of Xylem Inc. (NYSE:XYL)

Mercer Global Advisors Inc. ADV raised its holdings in shares of Xylem Inc. (NYSE:XYLGet Rating) by 1.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 15,757 shares of the industrial products company’s stock after acquiring an additional 294 shares during the quarter. Mercer Global Advisors Inc. ADV’s holdings in Xylem were worth $1,742,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors also recently modified their holdings of XYL. Continental Investors Services Inc. purchased a new stake in Xylem in the 3rd quarter valued at about $9,912,000. FORA Capital LLC purchased a new position in Xylem in the fourth quarter valued at $477,000. Pictet & Cie Europe SA lifted its position in shares of Xylem by 21.2% in the fourth quarter. Pictet & Cie Europe SA now owns 4,424 shares of the industrial products company’s stock valued at $489,000 after acquiring an additional 773 shares in the last quarter. Envestnet Asset Management Inc. lifted its stake in Xylem by 4.5% in the 3rd quarter. Envestnet Asset Management Inc. now owns 197,454 shares of the industrial products company’s stock worth $17,250,000 after purchasing an additional 8,566 shares in the last quarter. Finally, Brinker Capital Investments LLC increased its holdings in shares of Xylem by 15.8% during the 3rd quarter. Brinker Capital Investments LLC now owns 17,447 shares of the industrial products company’s stock worth $1,524,000 after buying an additional 2,377 shares during the last quarter. Hedge funds and other institutional investors own 83.57% of the company’s stock.

Insiders Place Their Bets

In other Xylem news, CEO Patrick Decker sold 56,298 shares of the company’s stock in a transaction dated Monday, March 13th. The shares were sold at an average price of $98.19, for a total transaction of $5,527,900.62. Following the transaction, the chief executive officer now directly owns 287,564 shares in the company, valued at $28,235,909.16. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other Xylem news, CEO Patrick Decker sold 56,298 shares of the company’s stock in a transaction dated Monday, March 13th. The shares were sold at an average price of $98.19, for a total transaction of $5,527,900.62. Following the transaction, the chief executive officer now directly owns 287,564 shares in the company, valued at $28,235,909.16. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, SVP Hayati Yarkadas sold 15,942 shares of the company’s stock in a transaction dated Thursday, March 2nd. The stock was sold at an average price of $100.43, for a total transaction of $1,601,055.06. Following the transaction, the senior vice president now owns 12,146 shares in the company, valued at $1,219,822.78. The disclosure for this sale can be found here. 0.90% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the stock. Cowen boosted their price target on shares of Xylem from $115.00 to $120.00 and gave the company an “outperform” rating in a research report on Tuesday, February 14th. Citigroup reduced their price target on shares of Xylem from $123.00 to $121.00 and set a “neutral” rating for the company in a research report on Wednesday, February 8th. Morgan Stanley lifted their price objective on shares of Xylem from $105.00 to $115.00 and gave the company an “overweight” rating in a research note on Wednesday, January 18th. TheStreet lowered shares of Xylem from a “b” rating to a “c+” rating in a research note on Thursday, May 4th. Finally, StockNews.com started coverage on shares of Xylem in a research note on Thursday, March 16th. They issued a “hold” rating on the stock. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and six have given a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $114.80.

Xylem Trading Down 1.3 %

Shares of Xylem stock opened at $103.26 on Wednesday. Xylem Inc. has a 52-week low of $72.08 and a 52-week high of $118.58. The company has a quick ratio of 1.44, a current ratio of 2.01 and a debt-to-equity ratio of 0.52. The company’s 50-day simple moving average is $102.25 and its 200-day simple moving average is $106.40. The firm has a market cap of $18.65 billion, a price-to-earnings ratio of 50.37, a price-to-earnings-growth ratio of 2.66 and a beta of 1.07.

Xylem (NYSE:XYLGet Rating) last issued its quarterly earnings results on Thursday, May 4th. The industrial products company reported $0.72 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.62 by $0.10. Xylem had a net margin of 6.53% and a return on equity of 16.63%. The business had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.35 billion. During the same period in the previous year, the business posted $0.47 earnings per share. The business’s revenue was up 13.8% compared to the same quarter last year. As a group, equities research analysts anticipate that Xylem Inc. will post 3.28 earnings per share for the current year.

Xylem Profile

(Get Rating)

Xylem, Inc engages in the design, manufacture, and application of engineered technologies for the water industry. It operates through the following business segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment focuses on the transportation, treatment and testing of water.

Featured Stories

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLGet Rating).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.